MannKind Corporation is a company in the U.S. stock market and it is a holding in 32 U.S.-traded ETFs. MNKD has around 30.0M shares in the U.S. ETF market. The largest ETF holder of MNKD is the SPDR S&P Biotech ETF (XBI), with approximately 13.35M shares. Investors may also find of interest that the ETF with the largest allocation to MNKD stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 2.21%. On average, U.S. ETFs allocate 0.17% of MNKD to their portfolios.
Additionally, MNKD is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MNKD as a holding is the iShares Morningstar Small-Cap ETF (ISCB), with a return of 592.66%.